{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T15:56:37Z","timestamp":1761580597180},"reference-count":13,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2008,4,1]],"date-time":"2008-04-01T00:00:00Z","timestamp":1207008000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Int J Clin Oncol"],"published-print":{"date-parts":[[2008,4]]},"DOI":"10.1007\/s10147-007-0702-x","type":"journal-article","created":{"date-parts":[[2008,5,7]],"date-time":"2008-05-07T10:21:10Z","timestamp":1210155670000},"page":"169-172","source":"Crossref","is-referenced-by-count":9,"title":["Small cell carcinoma of the prostate treated with amrubicin"],"prefix":"10.1007","volume":"13","author":[{"given":"Manabu","family":"Katou","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Norihito","family":"Soga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takehisa","family":"Onishi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kiminobu","family":"Arima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshiki","family":"Sugimura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2008,5,8]]},"reference":[{"key":"702_CR1","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1016\/S0022-5347(17)37427-X","volume":"147","author":"R.J. Amato","year":"1992","unstructured":"Amato RJ, Logothetis CJ, Hallinan R, et al. (1992) Chemotherapy for small cell carcinoma of prostatic origin. J Urol 147:935\u2013937","journal-title":"J Urol"},{"key":"702_CR2","doi-asserted-by":"crossref","first-page":"343","DOI":"10.3122\/jabfm.16.4.343","volume":"16","author":"C. Trotz","year":"2003","unstructured":"Trotz C (2003) Prostate cancer with a normal PSA: small cell carcinoma of the prostate\u2014a rare entity. J Am Board Fam Pract 16:343\u2013344","journal-title":"J Am Board Fam Pract"},{"key":"702_CR3","doi-asserted-by":"crossref","first-page":"75","DOI":"10.7888\/juoeh.28.75","volume":"28","author":"H. Uramoto","year":"2006","unstructured":"Uramoto H, Kagami S, Iwashige A, et al. (2006) Chemotherapy for lung cancer patients. J UOEH 28:75\u201384","journal-title":"J UOEH"},{"key":"702_CR4","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.urolonc.2005.08.022","volume":"24","author":"M. Yashi","year":"2006","unstructured":"Yashi M, Terauchi F, Nukui A, et al. (2006) Small-cell neuroendocrine carcinoma as a variant form of prostate cancer recurrence: a case report and short literature review. Urol Oncol 24:313\u2013317","journal-title":"Urol Oncol"},{"key":"702_CR5","first-page":"1100","volume":"112","author":"E.A. Turbat-Herrera","year":"1988","unstructured":"Turbat-Herrera EA, Herrera GA, Gore I, et al. (1988) Neuroendocrine differentiation in prostatic carcinomas. A retrospective autopsy study. Arch Pathol Lab Med 112:1100\u20131105","journal-title":"Arch Pathol Lab Med"},{"key":"702_CR6","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/0090-4295(92)90235-O","volume":"39","author":"S.R. Moore","year":"1992","unstructured":"Moore SR, Reinberg Y, Zhang G (1992) Small cell carcinoma of prostate: effectiveness of hormonal versus chemotherapy. Urology 39:411\u2013416","journal-title":"Urology"},{"key":"702_CR7","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1111\/j.1464-410X.2006.06041.x","volume":"97","author":"T.R. Asmis","year":"2006","unstructured":"Asmis TR, Reaume MN, Dahrouge S, et al. (2006) Genitourinary small cell carcinoma: a retrospective review of treatment and survival patterns at The Ottawa Hospital Regional Cancer Center. BJU Int 97:711\u2013715","journal-title":"BJU Int"},{"key":"702_CR8","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1007\/s004320050255","volume":"125","author":"M. Ogawa","year":"1999","unstructured":"Ogawa M (1999) Novel anticancer drugs in Japan. J Cancer Res Clin Oncol 125:134\u2013140","journal-title":"J Cancer Res Clin Oncol"},{"key":"702_CR9","first-page":"373","volume":"33","author":"J. Kurai","year":"2006","unstructured":"Kurai J, Igishi T, Suyama H, et al. (2006) A case of small-cell lung cancer effectively treated by bi-weekly administration of amrubicin. Japanese Journal of Cancer and Chemotherapy 33:373\u2013375","journal-title":"Japanese Journal of Cancer and Chemotherapy"},{"key":"702_CR10","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/s10637-006-5937-2","volume":"24","author":"T. Sawa","year":"2006","unstructured":"Sawa T, Yana T, Takada M, et al. (2006) Multicenter phase II study of amrubicin, 9-amino-anthracycline, in patients with advanced non-small-cell lung cancer (Study 1): West Japan Thoracic Oncology Group (WJTOG) trial. Invest New Drugs 24:151\u2013158","journal-title":"Invest New Drugs"},{"key":"702_CR11","first-page":"179","volume":"62","author":"T. Ikegami","year":"2002","unstructured":"Ikegami T, Ha L, Arimori K, et al. (2002) Intestinal alkalization as a possible preventive mechanism in irinotecan (CPT-11)-induced diarrhea. Cancer Res 62:179\u2013187","journal-title":"Cancer Res"},{"key":"702_CR12","first-page":"24","volume":"33","author":"K. Kandabashi","year":"2006","unstructured":"Kandabashi K, Sasaki T (2006) Management of chemotherapy-induced mucositis and diarrhea. Japanese Journal of Cancer and Chemotherapy 33:24\u201328","journal-title":"Japanese Journal of Cancer and Chemotherapy"},{"key":"702_CR13","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1097\/01.ftd.0000185771.82620.ee","volume":"28","author":"Y. Matsunaga","year":"2006","unstructured":"Matsunaga Y, Hamada A, Okamoto I, et al. (2006) Pharmacokinetics of amrubicin and its active metabolite amrubicinol in lung cancer patients. Ther Drug Monit 28:76\u201382","journal-title":"Ther Drug Monit"}],"container-title":["International Journal of Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10147-007-0702-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10147-007-0702-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10147-007-0702-x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,29]],"date-time":"2019-05-29T20:24:46Z","timestamp":1559161486000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10147-007-0702-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,4]]},"references-count":13,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2008,4]]}},"alternative-id":["702"],"URL":"https:\/\/doi.org\/10.1007\/s10147-007-0702-x","relation":{},"ISSN":["1341-9625","1437-7772"],"issn-type":[{"value":"1341-9625","type":"print"},{"value":"1437-7772","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,4]]}}}